Hong Kong-listed Insilico Medicine has reached a deal with U.S. pharma giant Eli Lilly for AI-discovered drugs. The two companies have worked together since 2023. Insilico's CEO, Alex Zhavoronkov, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Eli Lilly's oral GLP-1 agonist orforglipron was more effective than Novo Nordisk's rival oral formulation of semaglutide in a head-to-head diabetes trial, but likely won't answer the question of which ...

The brief reign of Novo Nordisk’s Wegovy pill as the lone oral GLP-1 approved for obesity has ended as Eli Lilly’s orforglipron cruised past an FDA green light Wednesday. Now christened Foundayo, the ...

April 1 (Reuters) - The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up its next battle with rival Novo Nordisk for the millions of Americans seeking highly effective GLP-1 ...

The Cobble Hill townhouse hit the market last October for $7.9 million just days after the release of her widely discussed ...

Eli Lilly (LLY) struck a new agreement with Insilico Medicine (ISLMF) that could be worth as much as $2.75 billion, deepening its investment in artificial intelligence for drug development. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

Eli Lilly has made yet another deal, this time buying a drug company that’s developing a therapy for narcolepsy for up to $7.8 billion. It’s acquiring Centessa Pharmaceuticals, which is working on ...

The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug ...

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. US drugmaker Eli Lilly has signed a $2bn deal with a Hong Kong-listed company that uses AI for drug ...